Antoinette Coe, PharmD, PhD
College of Pharmacy
428 Church St
Ann Arbor, MI 48109-1065
Dr. Antoinette (Toni) B. Coe joined the University of Michigan in 2016 as a Research Assistant Professor. She received her PharmD from Virginia Commonwealth University (VCU) in 2009. In 2010, she completed a PGY-1 Community-Based Pharmacy Practice Residency with VCU School of Pharmacy/Martin’s Pharmacy. She then received her PhD in Pharmaceutical Sciences from VCU in 2015. She completed post-doctoral training as a 2016-2018 Clinician Scholar in the University of Michigan Institute for Healthcare Policy and Innovation (IHPI) Clinician Scholars program. In 2018, she transitioned to an Assistant Professor position.
Dr. Coe is a pharmacist-health services researcher devoted to improving transitions of care and ensuring safe and effective medication use in older adults, particularly in older adults with Alzheimer’s disease, related dementias, and cognitive impairment. Her research focuses on improving medication use through pharmacist-provided comprehensive medication reviews and medication management, identifying community-based strategies and interprofessional models of care to prevent medication-related problems during care transitions, and examining the impact of policy on health outcomes. Her work aims to implement and disseminate evidence-based interventions to improve health and medication use in older adults that address health disparities. Dr. Coe’s work has been funded by the National Institutes of Health (NIH) National Institute on Aging (NIA), the University of Michigan NIH NIA-funded Center to Accelerate Population Research in Alzheimer’s (CAPRA), the Michigan Region VII Area Agency on Aging, the Michigan Institute for Clinical and Health Research, and the American Foundation for Pharmaceutical Education.
Older adults are missing out on a crucial medication review service
Clashing medications can put older adults at risk, but many haven’t had a pharmacist check for safety concerns
Dropping the ball: Post ICU, many patients not getting the correct meds
Strategies to improve transitions of care and medication use in older adults with Alzheimer's disease and related dementias
Implementation and dissemination of pharmacist-provided comprehensive medication reviews to ensure safe and effective medication use in older adults
Impact of pharmacists' care on health outcomes in innovative, interprofessional patient care models
Strategies and policies which address health disparities to improve health and medication-related outcomes in older adults
Coe AB, Zhang T, Zullo AR, Gerlach LB, Thomas KS, Daiello LA, Varma H, Lo D, Joshi R, Shireman TI, Bynum JPW. Psychotropic medication prescribing in assisted living and nursing home residents with dementia after the National Partnership. J Am Geriatr Soc. 19 Aug 2022. Online ahead of print. doi: 10.1111/jgs.18004.
Coe AB, Farris KB, Solway E, Singer DC, Kirch M, Kullgren JT, Malani PN, Bynum JPW. Predictors of receipt of comprehensive medication reviews in older adults. J Gerontol A Biol Sci Med Sci. 21 April 2022. Online ahead of print. doi: 10.1093/gerona/glac096.
Coe AB, Adeoye-Olatunde OA, Pestka DL, Synder ME, Zillich AJ, Farris KB, Farley JF. Patterns and predictors of older adult Medicare Part D beneficiaries’ receipt of medication therapy management. Res Soc Adm Pharm. 2020;16(9):1208-1219.
Coe AB, Bynum JPW, Farris KB. Comprehensive medication review: New poll indicates interest but low receipt among older adults. JAMA Health Forum. 2020;1(10):e201243.
Coe AB, Choe HM, Diez HL, Rockey N, Ashjian EJ, Dorsch MP, Kim HM, Farris KB. Pharmacists providing care in statewide physician organizations: Findings from the Michigan Pharmacists Transforming Care and Quality (MPTCQ) Collaborative. J Manag Care Spec Pharm. 2020;26(12):1588-66.
Coe AB, Vincent BM, Iwashyna TJ. Statin discontinuation and new antipsychotic use after an acute hospital stay vary by hospital. PLoS ONE. 2020;15(5):e0232702.
Pestka DL, Zillich AJ, Coe AB, Farris KB, Adeoye OA, Snyder ME, Farley JF. Nationwide estimates of medication therapy management delivery under the Medicare prescription drug benefit. J Am Pharm Assoc. 2020;60(3):456-461.